AFGAS
BMRN icon

Allegiance Financial Group Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,063
Closed -$217K – 159
2025
Q1 		$217K Buy
+3,063
New +$217K 0.07% 122